The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1423
ISSUE1423
August 19, 2013
Bedaquiline (Sirturo) for Multidrug-Resistant Tuberculosis
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Bedaquiline (Sirturo) for Multidrug-Resistant Tuberculosis
August 19, 2013 (Issue: 1423)
Bedaquiline (bed ak' wi leen; Sirturo – Janssen), a
diarylquinoline antimycobacterial, has been given
accelerated approval by the FDA as an orphan drug
for use in addition to other drugs for treatment of adults
with multidrug-resistant...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.